id:"swepub:oai:gup.ub.gu.se/50280"
Search: id:"swepub:oai:gup.ub.gu.se/50280" > Tissue-specific tar...
- 1 of 1
- Previous record
- Next record
- To hitlist
Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges
-
- Beck, Caroline, 1976 (author)
- Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
- Uramoto, Hidetaka (author)
-
- Borén, Jan, 1963 (author)
- Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
- show more...
- show less...
- (creator_code:org_t)
- 2004
- 2004
- English.
- In: Current Gene Therapies. - 1566-5232. ; 4:4, s. 457-67
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- The introduction of genes to cardiovascular cells in vivo remains the major challenge for current gene therapy modalities. However, recent developments in retargeting adenoviral vectors are promising to improve transduction efficiency in the cardiovascular cells. After systemic application, most adenoviral vectors are trapped by the liver, hampering delivery to target cardiovascular tissues. Furthermore, a majority of vectors for vascular gene transfer utilizes strong heterologous viral promoters, such as CMV. A potential side effect related to the use of such vectors is the systemic organ toxicity resulting from unrestricted transgene expression. These vectors have the additional problem of being frequently shut-down in vivo. Therefore, both retargeting adenoviral vectors and the use of tissue-specific promoter-driven vectors offer an enhanced safety profile by reducing ectopic expression in vital organs including the liver and lung. However, the limiting factor for the use of tissue-specific promoters is the low-level of expression compared with their viral counterparts. Both the development of efficient and strong vectors using cell-specific regulatory elements and the production of therapeutic proteins at sufficient levels is urgently needed to inhibit vasculoproliferative disorders. This review will focus on some of the recent achievements in vector development relevant to the delivery of vascular gene therapies targeted to the vascular endothelium, smooth muscle cells and macrophages during arterial remodelling.
Keyword
- Adenoviridae/genetics
- Animals
- Cardiovascular System/*metabolism
- Endothelium
- Vascular/metabolism
- Gene Expression
- Gene Therapy/*methods/trends
- Gene Transfer Techniques
- Genetic Engineering
- *Genetic Vectors
- Humans
- Macrophages/metabolism
- Muscle
- Smooth
- Vascular/metabolism
- Organ Specificity
- Promoter Regions (Genetics)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Current Gene Therapies (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Beck, Caroline, ...
- Uramoto, Hidetak ...
- Borén, Jan, 1963
- Akyürek, Levent, ...
- Articles in the publication
- Current Gene The ...
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
